Researchers have developed a way to pull HIV out of the latent reservoir making the virus visible to the immune system and providing the potential to be killed by treatment.
Jul 9, 2020
0
57
Multiple tissues of the male genital tract can be infected with SARS-CoV-2, reports a new Northwestern Medicine study in large animal models. The study, in SARS-CoV-2 infected-rhesus macaques, revealed the prostate, vasculature ...
Mar 2, 2022
0
186
A plant-based antiviral treatment for Covid-19, recently discovered by scientists at the University of Nottingham, has been found to be just as effective at treating all variants of the virus SARS-CoV-2, even the highly infectious ...
Nov 19, 2021
1
140
Australian researchers have revealed—for the first time—that people who have been infected with the COVID-19 virus have immune memory to protect against reinfection for at least eight months.
Dec 22, 2020
3
3081
A study led by researchers from the LKS Faculty of Medicine at The University of Hong Kong (HKUMed) provides the first information on how the novel Variant of Concern (VOC) of SARS-CoV-2, the omicron SARS-CoV-2 infect human ...
Dec 20, 2021
0
25
Once herpes simplex infects a person, the virus goes into hiding inside nerve cells, hibernating there for life, periodically waking up from its sleep to reignite infection, causing cold sores or genital lesions to recur.
Mar 15, 2018
0
81
Several coronaviruses circulate worldwide and constantly infect humans, which normally causes only mild respiratory disease. Currently, however, we are witnessing a worldwide spread of a new coronavirus with more than 90,000 ...
Mar 5, 2020
0
775
As the coronavirus spreads and fear grows, people are taking an abundance of precautions to keep from contracting it.
Mar 16, 2020
5
101
COVID-19 reactivated viruses that had become latent in cells following previous infections, particularly in people with chronic fatigue syndrome, also known as ME/CFS. This is the conclusion of a study from Linköping University ...
Nov 16, 2022
0
103
Scientists at Washington University School of Medicine in St. Louis have developed a vaccine that targets the SARS-CoV-2 virus, can be given in one dose via the nose and is effective in preventing infection in mice susceptible ...
Aug 21, 2020
0
720
